Dernièrement…

🌱 En direct du Congrès « Natural Products and Biocontrol 2022 » à Perpignan.
Ce matin, notre #BusinessDeveloper a pris la parole lors d’une session dédiée afin de présenter notre agent de #biocontrôle et nos #résultats d’#essais prometteurs sur différentes #cultures agricoles.

📣 Communiqué de Presse : https://bit.ly/3BF5U2B
#Amoéba annonce l’émission de la sixième tranche de 60 obligations convertibles en actions (#OCA) dans le cadre de son #financement obligataire avec programme d’intéressement conclu avec Nice & Green S.A.

🌿Retrouvez les équipes d’#Amoéba au #Congrès Natural Products and Biocontrols 2022 à Perpignan, du 20 au 23 septembre prochain.
Notre #BusinessDeveloper présentera notre solution de #biocontrôle et ses résultats #efficacité sur diverses #cultures devant les experts du domaine.

+70% pour @AmoebaNature alors que l'Agence américaine pour la protection de l'environnement a émis une pré-décision favorable après avoir évalué sa demande d'autorisation de 'Willaertia magna C2c Maky' https://www.boursorama.com/bourse/actualites/amoeba-vers-un-feu-vert-de-l-epa-pour-son-amibe-biocide-59c2a82b84038127133be13ae23167f9?symbol=1rPALMIB

Ordinary and extraordinary general meeting to be held on 24 May 2022

Ordinary and extraordinary general meeting to be held on 24 May 2022 – Modalities through which the preparatory documents will be made available

The company’s shareholders are invited to attend the ordinary and extraordinary general
meeting which will be held on: Tuesday 24 may 2022 – 9 am at the company registered office – 38 Avenue des Frères Montgolfier- 69680 CHASSIEU.

The notice of the meeting as a notice of convocation, including the agenda and the planned
resolutions, was published in the BALO (Bulletin of obligatory legal announcements) of 18 april, 2022.
The documents stipulated by article R.225-83 of the French commercial code are available to
shareholders from the moment that the assembly is convened, in line with the applicable regulatory
requirements:
• Any registered shareholder can, until the fifth day (inclusive) before the assembly, ask the
company to send him these documents. For holders of bearer shares, this right can only be
exercised upon presentation of a statement of participation in the accounts of bearer shares
held by the authorised intermediary;
• Any shareholder can consult these documents at the company’s headquarters during the 15
days preceding the date of the meeting.

For information, electronic voting via the VOTACCESS secure voting platform for the General Meeting
of Tuesday, May 24, 2022 will be open from May 6, 2022 until Monday, May 23, 2022 at 3:00 pm (Paris
time). Shareholders wishing to use this platform can consult the access conditions in the notice of
meeting and on the company’s website (https://amoeba-nature.com/investisseur/assembleegenerale).

In the context of the coronavirus epidemic (COVID-19), the procedures for holding the Shareholders’
Meeting may change depending on health and/or legal requirements. Shareholders are invited to
regularly consult the section dedicated to the Shareholders’ Meeting on the Company’s website
(https://www.amoeba-nature.com/Investors/General-assembly).
The results of the votes on resolutions will be posted on the Company’s website.